Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-cyclodextrin is a cyclic oligosaccharide composed of six α-(1→4) linked D-glucopyranose units. It is produced from starch by enzymatic conversion and belongs to the class of organic compounds known as oligosaccharides. Alpha-cyclodextrin acts primarily as a soluble dietary fiber with the ability to bind dietary fats in the gastrointestinal tract, thereby reducing their absorption. This mechanism can contribute to weight loss and improved metabolic parameters such as glucose metabolism and insulin sensitivity. It has also been investigated for its use as an excipient in pharmaceutical formulations to enhance drug solubility and bioavailability[1][2][3][4][5][6]. The compound is considered safe for human consumption with no significant side effects reported at recommended doses[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-cyclodextrin.